# Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

> **NCT05099770** · PHASE3 · RECRUITING · sponsor: **Prokidney** · enrollment: 685 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus
- Chronic Kidney Diseases

## Interventions

- **BIOLOGICAL:** Renal Autologous Cell Therapy (REACT/ rilparencel)
- **PROCEDURE:** Sham Comparator

## Key facts

- **NCT ID:** NCT05099770
- **Lead sponsor:** Prokidney
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-05
- **Primary completion:** 2029-12
- **Final completion:** 2029-12
- **Target enrollment:** 685 (ESTIMATED)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05099770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05099770, "Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05099770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*